Lyra Therapeutics (NASDAQ:LYRA)
Transmucosal drug delivery platform for the treatment of chronic rhinosinusitis.
Get a Demo and See the Full Profile
Get a demo today to see profiles of Lyra Therapeutics (NASDAQ:LYRA) plus 5917 other startups.
